| Cefprozil |
II-9439/03.08.2004 |
CEFZIL, Powder for oral suspension, 125 mg/5 ml - 60 ml, mg, Pack: 1 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Corden Pharma Latina S.p.A., via del Murillo Km 2.800 Sermoneta, Latina, Италия |
9.66 |
1.93 |
11.59 |
7% |
0.68 |
10.34 |
2.07 |
12.41 |
20% |
1.93 |
12.27 |
2.45 |
14.72 |
промяна на обстоятелства НСР-944/12.08.2013; НСР-4803/13.10.2014 |
КЦ-497/04.02.2009 |
10.03.2009 |
10.03.2009 |
Неактивен |
468 |
| Cefprozil |
II-9440/03.08.2004 |
CEFZIL, Powder for oral suspension, 250 mg/5 ml - 60 ml, mg, Pack: 1 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
PharmaSwiss d.o.o., Словения |
11.27 |
2.25 |
13.52 |
6% |
0.68 |
11.95 |
2.39 |
14.34 |
18% |
2.03 |
13.98 |
2.8 |
16.78 |
промяна на обстоятелства НСР-6263/21.05.2015 |
НСР-5652/18.02.2015 |
09.03.2015 |
09.03.2015 |
Неактивен |
3637 |
| Cefprozil |
II-9440/03.08.2004 |
CEFZIL, Powder for oral suspension, 250 mg/5 ml - 60 ml, mg, Pack: 1 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Corden Pharma Latina S.p.A., via del Murillo Km 2.800 Sermoneta, Latina, Италия |
11.73 |
2.35 |
14.08 |
6% |
0.7 |
12.43 |
2.49 |
14.92 |
18% |
2.11 |
14.54 |
2.91 |
17.45 |
промяна на обстоятелства НСР-4801/13.10.2014 |
НСР-3658/29.05.2014 |
18.06.2014 |
18.06.2014 |
Неактивен |
3637 |
| Cefprozil |
II-9440/03.08.2004 |
CEFZIL, Powder for oral suspension, 250 mg/5 ml - 60 ml, mg, Pack: 1 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Bristol-Myers Squibb S.p.A., via del Morillo, 04019 Sermoneta (Latina), Italy |
12.28 |
2.46 |
14.74 |
6% |
0.74 |
13.02 |
2.6 |
15.62 |
18% |
2.21 |
15.23 |
3.05 |
18.28 |
промяна на обстоятелства НСР-944/12.08.2013 |
КЦ-497/04.02.2009 |
10.03.2009 |
10.03.2009 |
Неактивен |
3637 |
| Celecoxib |
II-0425/09.08.2007 |
CELEBREX, Capsule, hard, 200, mg, Pack: 30 |
Pfizer Europe MA EEIG, Обединено Кралство |
Piramal Healthcare UK Limited, UK; Pfizer Manufacturing Deutschland GmbH, Heinrich-Mack-Strasse 35, 89257 Illertissen, Germany |
24.27 |
4.85 |
29.12 |
6% |
1.46 |
25.73 |
5.15 |
30.88 |
18% |
4.37 |
30.1 |
6.02 |
36.12 |
Промяна на обстоятелства и вписване на цената в регистъра на пределните цени с решение НСР-4230/30.07.2014 |
НСР-2218/20.12.2013 |
04.01.2014 |
04.01.2014 |
Заличен |
2378 |
| Celecoxib |
II-0425/09.08.2007 |
CELEBREX, Capsule, hard, 200, mg, Pack: 30 |
Pfizer Europe MA EEIG, Обединено Кралство |
NPIL Pharmaceuticals (UK) Ltd.Whalton Road, Morepeth, Northumberland NE61 3YA, UK; Pfizer Manufacturing Deutschland GmbH, Heinrich-Mack-Strasse 35, 89257 Illertissen, Germany |
25.15 |
5.03 |
30.18 |
6% |
1.51 |
26.66 |
5.33 |
31.99 |
18% |
4.53 |
31.19 |
6.24 |
37.43 |
|
КЦ-3193/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
2378 |
| Celecoxib |
II-0425/09.08.2007 |
CELEBREX, Capsule, hard, 200, mg, Pack: 30 |
Pfizer Europe MA EEIG, Обединено Кралство |
NPIL Pharmaceuticals (UK) Ltd.Whalton Road, Morepeth, Northumberland NE61 3YA, UK; Pfizer Manufacturing Deutschland GmbH, Heinrich-Mack-Strasse 35, 89257 Illertissen, Germany |
33.58 |
6.72 |
40.3 |
4% |
1.34 |
34.92 |
6.98 |
41.9 |
16% |
5.37 |
40.29 |
8.06 |
48.35 |
|
КЦ-707/09.03.2009 |
25.03.2009 |
25.03.2009 |
Неактивен |
2378 |
| Celecoxib |
II-0425/09.08.2007 |
CELEBREX, Capsule, hard, 200, mg, Pack: 10 |
Pfizer Europe MA EEIG, Обединено Кралство |
Piramal Healthcare UK Limited, UK; Pfizer Manufacturing Deutschland GmbH, Heinrich-Mack-Strasse 35, 89257 Illertissen, Germany |
9.19 |
1.84 |
11.03 |
7% |
0.64 |
9.83 |
1.97 |
11.8 |
20% |
1.84 |
11.67 |
2.33 |
14 |
Промяна на обстоятелства и вписване на цената в регистъра на пределните цени с решение НСР-4229/30.07.2014 |
НСР-2218/20.12.2013 |
04.01.2014 |
04.01.2014 |
Заличен |
2377 |
| Celecoxib |
II-0425/09.08.2007 |
CELEBREX, Capsule, hard, 200, mg, Pack: 10 |
Pfizer Europe MA EEIG, Обединено Кралство |
NPIL Pharmaceuticals (UK) Ltd.Whalton Road, Morepeth, Northumberland NE61 3YA, UK; Pfizer Manufacturing Deutschland GmbH, Heinrich-Mack-Strasse 35, 89257 Illertissen, Germany |
10.17 |
2.03 |
12.2 |
6% |
0.61 |
10.78 |
2.16 |
12.94 |
18% |
1.83 |
12.61 |
2.52 |
15.13 |
|
КЦ-3193/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
2377 |
| Celecoxib |
II-0425/09.08.2007 |
CELEBREX, Capsule, hard, 200, mg, Pack: 10 |
Pfizer Europe MA EEIG, Обединено Кралство |
NPIL Pharmaceuticals (UK) Ltd.Whalton Road, Morepeth, Northumberland NE61 3YA, UK; Pfizer Manufacturing Deutschland GmbH, Heinrich-Mack-Strasse 35, 89257 Illertissen, Germany |
11.21 |
2.24 |
13.45 |
6% |
0.67 |
11.88 |
2.38 |
14.26 |
18% |
2.02 |
13.9 |
2.78 |
16.68 |
|
КЦ-707/09.03.2009 |
25.03.2009 |
25.03.2009 |
Неактивен |
2377 |
| Mycophenolic acid |
EU/1/96/005/002 |
CellCept, Tablet, 500, mg, Pack: 50 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
94.82 |
18.96 |
113.78 |
4% |
3.79 |
98.61 |
19.72 |
118.33 |
16% |
15.17 |
113.78 |
22.76 |
136.54 |
цената се заличава КЦРР-1331/21.08.2012 |
КЦРР-278/06.03.2012 |
27.03.2012 |
27.03.2012 |
Заличен |
1144 |
| Mycophenolic acid |
EU/1/96/005/002 |
CellCept, Tablet, 500, mg, Pack: 50 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
194.14 |
38.83 |
232.97 |
6% |
11.65 |
205.79 |
41.16 |
246.95 |
18% |
30 |
235.79 |
47.16 |
282.95 |
|
КЦ-529/13.02.2009 |
02.03.2009 |
02.03.2009 |
Неактивен |
1144 |
| Mycophenolic acid |
EU/1/96/005/001 |
CellCept, Capsule, hard, 250, mg, Pack: 100 |
Roche Registration GmbH, Германия |
Roche Pharma AG - Germany |
63.51 |
12.7 |
76.21 |
4% |
2.54 |
66.05 |
13.21 |
79.26 |
16% |
10.16 |
76.21 |
15.24 |
91.45 |
Промяна на обстоятелствата НСР-15776/25.05.2018. |
НСР-1918/27.11.2013; НСР-16404/09.08.2018 (предварително изпълнение) |
09.08.2018 |
02.09.2018 |
Активен |
2332 |
| Mycophenolic acid |
EU/1/96/005/001 |
CellCept, Capsule, hard, 250, mg, Pack: 100 |
Roche Registration GmbH, Германия |
Roche Pharma AG - Germany |
63.51 |
12.7 |
76.21 |
4% |
2.54 |
66.05 |
13.21 |
79.26 |
16% |
10.16 |
76.21 |
15.24 |
91.45 |
Промяна на обстоятелствата НСР-15776/25.05.2018. |
НСР-1918/27.11.2013; НСР-16404/09.08.2018 (предварително изпълнение) |
09.08.2018 |
02.09.2018 |
Неактивен |
2332 |
| Mycophenolic acid |
EU/1/96/005/001 |
CellCept, Capsule, hard, 250, mg, Pack: 100 |
Roche Registration GmbH, Германия |
Roche Pharma AG - Germany |
68.65 |
13.73 |
82.38 |
4% |
2.75 |
71.4 |
14.28 |
85.68 |
16% |
10.98 |
82.38 |
16.48 |
98.86 |
Промяна на обстоятелствата НСР-15776/25.05.2018. |
НСР-1918/27.11.2013 |
19.12.2013 |
02.07.2018 |
Неактивен |
2332 |
| Mycophenolic acid |
EU/1/96/005/001 |
CellCept, Capsule, hard, 250, mg, Pack: 100 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
68.65 |
13.73 |
82.38 |
4% |
2.75 |
71.4 |
14.28 |
85.68 |
16% |
10.98 |
82.38 |
16.48 |
98.86 |
|
НСР-1918/27.11.2013 |
19.12.2013 |
19.12.2013 |
Неактивен |
2332 |
| Mycophenolic acid |
EU/1/96/005/001 |
CellCept, Capsule, hard, 250, mg, Pack: 100 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
94.82 |
18.96 |
113.78 |
4% |
3.79 |
98.61 |
19.72 |
118.33 |
16% |
15.17 |
113.78 |
22.76 |
136.54 |
|
КЦРР-278/06.03.2012 |
27.03.2012 |
27.03.2012 |
Неактивен |
2332 |
| Mycophenolic acid |
EU/1/96/005/001 |
CellCept, Capsule, hard, 250, mg, Pack: 100 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
194.14 |
38.83 |
232.97 |
6% |
11.65 |
205.79 |
41.16 |
246.95 |
18% |
30 |
235.79 |
47.16 |
282.95 |
|
КЦ-529/13.02.2009 |
02.03.2009 |
02.03.2009 |
Неактивен |
2332 |
| Mycophenolic acid |
EU/1/96/005/006 |
CellCept, Powder for oral suspension, 110, g, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
269.85 |
53.97 |
323.82 |
4% |
10 |
279.85 |
55.97 |
335.82 |
16% |
25 |
304.85 |
60.97 |
365.82 |
цената се заличава КЦРР-2334/21.02.2013 |
КЦРР-216/27.02.2012 |
13.03.2012 |
13.03.2012 |
Заличен |
1143 |
| Mycophenolic acid |
EU/1/96/005/006 |
CellCept, Powder for oral suspension, 110, g, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
271.82 |
54.36 |
326.18 |
6% |
15 |
286.82 |
57.36 |
344.18 |
18% |
30 |
316.82 |
63.36 |
380.18 |
|
КЦ-529/13.02.2009 |
02.03.2009 |
02.03.2009 |
Неактивен |
1143 |
| Maraviroc |
EU/1/07/418/008 |
Celsentri, Film coated tablet, 300, mg, Pack: 60 |
Viiv Healthcare BV, Нидерландия |
Pfizer Manufacturing Deutschland GmbH, Германия |
1039.68 |
207.94 |
1247.62 |
4% |
10 |
1049.68 |
209.94 |
1259.62 |
16% |
25 |
1074.68 |
214.94 |
1289.62 |
Промяна на обстоятелства НСР-18153/07.03.2019 |
НСР-8333/26.02.2016; НСР-12479/28.04.2017 г.; НСР-15082/23.02.2018; НСР-17252/14.11.2018 |
29.11.2018 |
02.04.2019 |
Активен |
3473 |
| Maraviroc |
EU/1/07/418/008 |
Celsentri, Film coated tablet, 300, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1039.68 |
207.94 |
1247.62 |
4% |
10 |
1049.68 |
209.94 |
1259.62 |
16% |
25 |
1074.68 |
214.94 |
1289.62 |
|
НСР-8333/26.02.2016; НСР-12479/28.04.2017 г.; НСР-15082/23.02.2018; НСР-17252/14.11.2018 |
29.11.2018 |
02.12.2018 |
Неактивен |
3473 |
| Maraviroc |
EU/1/07/418/003 |
Celsentri, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare BV, Нидерландия |
Pfizer Manufacturing Deutschland GmbH, Германия |
1039.68 |
207.94 |
1247.62 |
4% |
10 |
1049.68 |
209.94 |
1259.62 |
16% |
25 |
1074.68 |
214.94 |
1289.62 |
Промяна на обстоятелства НСР-18153/07.03.2019 |
НСР-8328/26.02.2016; НСР-12480/28.04.2017 г.; НСР-15083/23.02.2018; НСР-17254/14.11.2018 |
29.11.2018 |
02.04.2019 |
Активен |
3472 |
| Maraviroc |
EU/1/07/418/003 |
Celsentri, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1039.68 |
207.94 |
1247.62 |
4% |
10 |
1049.68 |
209.94 |
1259.62 |
16% |
25 |
1074.68 |
214.94 |
1289.62 |
|
НСР-8328/26.02.2016; НСР-12480/28.04.2017 г.; НСР-15083/23.02.2018; НСР-17254/14.11.2018 |
29.11.2018 |
02.12.2018 |
Неактивен |
3472 |
| Maraviroc |
EU/1/07/418/003 |
Celsentri, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1082.51 |
216.5 |
1299.01 |
4% |
10 |
1092.51 |
218.5 |
1311.01 |
16% |
25 |
1117.51 |
223.5 |
1341.01 |
|
НСР-8328/26.02.2016; НСР-12480/28.04.2017 г.; НСР-15083/23.02.2018 |
10.03.2018 |
02.04.2018 |
Неактивен |
3472 |